<p>Hypoxia activated prodrugs, such as, e.g., TH-281, TH-302, and TH-308, are useful for the treatment of various blood cancers, such as acute leukemias, chronic leukemias, MDS, MF, and multiple myeloma.</p>
申请公布号
MX2012014416(A)
申请公布日期
2013.02.27
申请号
MX20120014416
申请日期
2011.06.27
申请人
THRESHOLD PHARMACEUTICALS, INC.
发明人
JOHN CURD;DAMIAN HANDISIDES;CHARLES HART;STEWART KROLL
